Trupanion

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Trupanion reports robust 2022 growth, eyes international expansion opportunities

Trupanion delivered strong financial performance in 2022, with significant revenue and income growth driven by pet acquisitions and retention strategies.
The company's focus on efficient capital deployment, expansion into new channels, and cash reserve position it well for future growth and profitability.
While facing challenges from pricing dynamics and international expansion, Trupanion's strategic initiatives present opportunities for sustained growth and market expansion.
With a positive outlook for 2023 and a solid foundation of customer data, Trupanion is poised to leverage its strengths and navigate challenges for continued success.

Trupanion reports robust Q1 earnings, eyes global expansion opportunities

Trupanion's Q1 2023 earnings call showcased strong financial performance, strategic focus on managing challenges related to inflation, and opportunities for global expansion and market growth. The company's effective pricing strategies and emphasis on long-term vision position it well for revenue growth and margin expansion in 2023.

Trupanion reports robust Q2 performance, eyes growth opportunities ahead

Trupanion's Q2 2023 performance reflects strong revenue growth, margin stabilization, and strategic cost management.
The company aims for disciplined growth, margin expansion, and sustained ARPU amidst challenges in revenue diversification and cost optimization.
Opportunities lie in continued rate increases, marketing efficiency improvements, and enhanced reporting for customer engagement and financial performance.

Trupanion reports robust Q3 earnings, eyes disciplined growth strategies

Trupanion's Q3 performance reflects strong revenue growth, margin expansion, and improved cash flow, underpinned by pricing power and customer loyalty.
While facing challenges in diversifying revenue streams and entering new markets, the company is well-positioned to leverage growth opportunities and maintain financial stability.
With a focus on disciplined growth, operational efficiency, and strategic investments, Trupanion aims to sustain positive momentum and capitalize on the growing pet insurance market.

Trupanion reports robust Q4 growth, focuses on margin expansion

Trupanion's Q4 performance reflects resilience amid industry challenges, with a strong focus on sustainable growth and financial discipline. The company's strategic initiatives to enhance member experience, prioritize margin expansion, and optimize capital deployment position it well for future opportunities.

Trupanion reports robust Q1 performance amidst market challenges and opportunities

Trupanion's Q1 2024 performance reflects strong revenue growth, margin expansion, and operational improvements driven by customer-centric strategies and efficient capital deployment.
While facing challenges such as inflation impacts and remediation efforts, the company's focus on margin expansion, market opportunities, and strategic initiatives positions it for future growth.
Investors can be optimistic about Trupanion's ability to navigate challenges, capitalize on growth opportunities, and drive profitability through effective pricing and operational efficiency.

Trupanion reports robust Q3 performance, eyes growth opportunities in Europe

Trupanion's Q3 performance reflects strong growth in subscription income and strategic initiatives to drive profitability and market expansion.
While challenges persist with inflation and cost management, the company's focus on efficiency and growth presents opportunities for sustained success.
Investors should note the positive operational improvements, the strategic market expansion into Europe, and the commitment to achieving sustainable margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

First Majestic Silver

Aimmune Therapeutics

Antero Midstream Partners

Amarin Corporation Plc

Exelixis

Intercept Pharma

Innovative Industrial Properties

Lovesac Company

Livongo Health Inc

Meet Group

Ping Identity Holding Corp

Pinterest

Redfin

Stitch Fix

StoneCo

Teva Pharmaceutical

Big gains could be just a click of the buy button away.

20 Stocks That Could Double Your Money in 2020

Trupanion, Inc. (TRUP) CEO Darryl Rawlings on Q3 2019 Results - Earnings Call Transcript

Trupanion (TRUP) delivered earnings and revenue surprises of 200.00% and 1.92%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Trupanion (TRUP) Q3 Earnings and Revenues Beat Estimates

Pet insurer Trupanion is in high-growth mode. It has explosive sales growth and could do even better on the bottom line.

This Insurance Company Could Quadruple Revenue Over the Next Decade

Is Trupanion an insurance company or a consumer subscription business? And why does it matter?

Investors Are Debating What Kind of Company Trupanion Is. Here's Why

MightyVet connects industry professionals in Australia and beyond with valuable resources Focuses on burnout, compassion fatigue, ethics exhaustion, resiliency, and suicide prevention

Trupanion Supports Australia’s Veterinary Professionals in their Mental Wellbeing through MightyVet

Company founded in Canada in 2000  More than $250 million paid out to Canadian pet owners since company’s inception

Trupanion Ranked #1 Medical Insurance Provider for Pets in Canada

But growth was still solid. How does it all balance out?

Trupanion's Spending a Lot More to Get Pets Into Its Ecosystem

Trupanion, Inc.'s (TRUP) CEO Darryl Rawlings on Q2 2019 Results - Earnings Call Transcript

IDEXX Laboratories

With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.

2 Stocks to Play the Pet Care Trend

Travelers

UnitedHealth Group

These insurers could produce excellent returns in the coming years.

3 Top Insurance Stocks to Buy Now

Trupanion Keeps Adding Pets, but at a Cost

Trupanion, Inc. (TRUP) CEO Darryl Rawlings on Q1 2019 Results - Earnings Call Transcript

Trupanion is a pet insurance company that wall street wants to be a SAAS company.

Trupanion: Industry M&A Comp Puts $9 Price Target On The Stock

The pet insurance company's stock has tripled over the last three years.

Why Trupanion Stock Gained 14.3% in February

On March, 7, Eli Hoffman launched a new contest, "Finding A Pone Stock" offering a $150 bounty for the five best articles.

Trupanion: The Anti-Pone Challenge Winner

News for Trupanion Stock (TRUP)